BioLargo, Inc. (OTCQB:BLGO) is a leading brand that specializes in inventing, developing, and commercializing innovative platform technologies to address complex environmental issues. With a strong focus on solving problems such as PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control, BioLargo is dedicated to making a positive impact on the environment.

With over thirteen years of extensive research and development, BioLargo holds a wide range of issued patents and maintains a robust pipeline of products. The brand also offers full-service environmental engineering and has established itself as a trusted partner with academic, municipal, and commercial organizations. BioLargo's approach centers around collaboration and innovation.

By utilizing a peer-reviewed scientific approach, the brand invents or acquires cutting-edge technologies and develops them to maturity through its operating subsidiaries. This dedication to excellence has resulted in over 90 awarded grants and numerous successful pilot projects. BioLargo monetizes its technologies through various channels such as direct sales, recurring service contracts, licensing agreements, strategic joint ventures, and the sale of intellectual property.

Many of its technologies are already commercially available and are making significant advancements as disruptors in their respective markets. At BioLargo, the driving force behind their work is the belief that their products and solutions can truly make life better. This passion stems from founder Ken Code's personal experience in developing a technology to combat nosocomial infections, which greatly improved his father's quality of life.

Guided by this core principle, BioLargo continues to create technology solutions that mimic natural processes in order to provide sustainable and effective environmental solutions